


CastleVax Revenue
Biotechnology Research • • 1-10 Employees
CastleVax revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | $34,000,000 |
Key Contact at CastleVax
Danny Wood
Director Clinical Operations
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
| Socials |
CastleVax Email Formats
CastleVax uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@castlevax.com), used 66.7% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@castlevax.com | 66.7% |
{first initial}.{last name} | j.doe@castlevax.com | 33.3% |
About CastleVax
CastleVax is the proven technology that will bring safe vaccines for all humans, everywhere. Our state-of-the-art platform for producing first-in-class vaccines uses Newcastle Disease Virus (NDV) to enable rapid development of safe and highly immunogenic viral vectors that are easy to deliver and store, and can be administered via injection or intranasally.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
CastleVax Tech Stack
Discover the technologies and tools that power CastleVax's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
JavaScript libraries
Security
Ecommerce
JavaScript libraries
Hosting
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
Frequently asked questions
4.8
40,000 users



